Difference between revisions of "STBT5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
(10 intermediate revisions by 2 users not shown) | |||
Line 5: | Line 5: | ||
If empty (no name is present), please volunteer to create content for that disease! | If empty (no name is present), please volunteer to create content for that disease! | ||
− | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | + | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br /> |
− | + | __TOC__ | |
− | <br /> | ||
{| class="wikitable" style="margin:auto" | {| class="wikitable" style="margin:auto" | ||
|+<big>WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content</big> | |+<big>WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content</big> | ||
Line 19: | Line 18: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
− | |||
− | |||
| | | | ||
− | | | + | ==== CHAPTER 2 (SOFT TISSUE TUMOURS) ==== |
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
| | | | ||
− | + | ---- | |
| | | | ||
+ | ---- | ||
| | | | ||
− | + | ---- | |
− | |||
− | |||
− | |||
− | |||
| | | | ||
− | + | ---- | |
| | | | ||
− | + | ---- | |
| | | | ||
− | + | ---- | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|[[STBT5:Lipoma|Lipoma]] | |[[STBT5:Lipoma|Lipoma]] | ||
Line 493: | Line 481: | ||
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]] | |[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]] | ||
|Disease | |Disease | ||
+ | |Shashi Shetty and Reba Daniel (resident) | ||
+ | |2/21/2024 | ||
| | | | ||
+ | |PENDING | ||
| | | | ||
+ | |Katherine Geiersbach | ||
| | | | ||
− | | | + | |Template added 2/21/2024 |
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]] | |[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]] | ||
Line 1,337: | Line 1,325: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | | | ||
+ | ==== CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE) ==== | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]] | |[[STBT5:Ewing_sarcoma|Ewing sarcoma]] | ||
Line 1,361: | Line 1,370: | ||
|- | |- | ||
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]] | |[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]] | ||
+ | |Disease | ||
+ | |Ganesh Pandurang, MD | ||
+ | |2/28/24 | ||
+ | | | ||
+ | |PENDING | ||
+ | | | ||
+ | |Katherine Geiersbach | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]] | ||
|Disease | |Disease | ||
| | | | ||
Line 1,371: | Line 1,391: | ||
| | | | ||
|- | |- | ||
− | |||
− | |||
| | | | ||
+ | ==== CHAPTER 4 (BONE TUMOURS) ==== | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
|[[STBT5:Subungual_exostosis|Subungual exostosis]] | |[[STBT5:Subungual_exostosis|Subungual exostosis]] | ||
Line 1,976: | Line 2,006: | ||
| | | | ||
|- | |- | ||
− | |||
− | |||
| | | | ||
+ | ==== CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE) ==== | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | |[[STBT5: | + | |[[STBT5:Enchondromatosis|Enchondromatosis]] |
|Disease | |Disease | ||
| | | | ||
Line 1,997: | Line 2,037: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
|- | |- | ||
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]] | |[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]] | ||
Line 2,022: | Line 2,073: | ||
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] | |[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]] | |[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]] |
Latest revision as of 13:47, 10 September 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.